U.S. Markets closed
  • S&P 500

    4,551.68
    -23.11 (-0.51%)
     
  • Dow 30

    35,490.69
    -266.19 (-0.74%)
     
  • Nasdaq

    15,235.84
    +0.12 (+0.00%)
     
  • Russell 2000

    2,252.49
    -43.58 (-1.90%)
     
  • Gold

    1,798.50
    +5.10 (+0.28%)
     
  • EUR/USD

    1.1606
    +0.0004 (+0.0348%)
     
  • 10-Yr Bond

    1.5290
    -0.0900 (-5.56%)
     
  • Vix

    16.98
    +1.00 (+6.26%)
     
  • GBP/USD

    1.3742
    -0.0022 (-0.1580%)
     
  • USD/JPY

    113.8300
    -0.2990 (-0.2620%)
     
  • BTC-USD

    58,815.76
    -3,300.45 (-5.31%)
     
  • CMC Crypto 200

    1,405.87
    -68.46 (-4.64%)
     
  • FTSE 100

    7,253.27
    -24.35 (-0.33%)
     
  • Nikkei 225

    29,098.24
    -7.76 (-0.03%)
     

Sundial Growers Inc. (SNDL) Gains As Market Dips: What You Should Know

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In the latest trading session, Sundial Growers Inc. (SNDL) closed at $0.82, marking a +0.23% move from the previous day. This move outpaced the S&P 500's daily loss of 0.54%.

Coming into today, shares of the company had lost 10.54% in the past month. In that same time, the Medical sector lost 3.77%, while the S&P 500 gained 3.05%.

SNDL will be looking to display strength as it nears its next earnings release. Our most recent consensus estimate is calling for quarterly revenue of $8 million, down 45.09% from the year-ago period.

SNDL's full-year Zacks Consensus Estimates are calling for earnings of -$0.08 per share and revenue of $65 million. These results would represent year-over-year changes of +69.23% and +24.93%, respectively.

It is also important to note the recent changes to analyst estimates for SNDL. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 366.67% lower. SNDL is currently sporting a Zacks Rank of #4 (Sell).

The Medical - Drugs industry is part of the Medical sector. This group has a Zacks Industry Rank of 213, putting it in the bottom 17% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sundial Growers Inc. (SNDL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research